MedPath

Feasibility study of postoperative adjuvant therapy using S-1 after curative esophagectomy for esophageal cancer

Not Applicable
Recruiting
Conditions
Esophageal cancer
Registration Number
JPRN-jRCT1060220042
Lead Sponsor
Hirahara Noriyuki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria

1) Histologically confirmed esophageal squamous cell carcinoma or adenocarcinoma.
2) Postoperative adjuvant chemotherap using S-a was performed.
3) Curative gastrectomy was performed.
4) Performance status of 0-1 on the Eastern Cooperative Oncology Group classification
5) No prior chemotherapy, radiation, endcrine, molecular targeted therapy within 5 years including treatment for other cancers,
6) Sufficient oral intake.

Exclusion Criteria

(1)Double cancer
(2)Heart failure, hepatitis, renal dysfunction
(3)Severe infection

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath